The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.
about
The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The Selective Angiotensin II T ...... Bleomycin-Induced Lung Injury.
@en
The Selective Angiotensin II T ...... Bleomycin-Induced Lung Injury.
@nl
type
label
The Selective Angiotensin II T ...... Bleomycin-Induced Lung Injury.
@en
The Selective Angiotensin II T ...... Bleomycin-Induced Lung Injury.
@nl
prefLabel
The Selective Angiotensin II T ...... Bleomycin-Induced Lung Injury.
@en
The Selective Angiotensin II T ...... Bleomycin-Induced Lung Injury.
@nl
P2093
P2860
P50
P356
P1476
The Selective Angiotensin II T ...... Bleomycin-Induced Lung Injury
@en
P2093
Alana Horowitz
Ashok Kumar
Diana Martinez
James West
Kelsey Horton
Michael J Katovich
Mohan K Raizada
Santhi Gladson
Thomas Unger
Vinayak Shenoy
P2860
P356
10.3389/FPHYS.2018.00180
P577
2018-03-27T00:00:00Z